¼¼°èÀÇ ´ÏƼ³î ±â¹Ý ÀÇ·á±â±â ½ÃÀå º¸°í¼­(2025³â)
Nitinol Based Medical Device Global Market Report 2025
»óǰÄÚµå : 1760653
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,272,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,065,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,859,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´ÏƼ³î ±â¹Ý ÀÇ·á ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ±Þ¼ÓÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¿¹»ó ¼ºÀåÀº ÃÖ¼Ò Ä§½À ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ·Îº¿ º¸Á¶ ¼ö¼ú¿¡¼­ ´ÏƼ³îÀÇ »ç¿ë Áõ°¡, ȯÀÚº° ¸ÂÃãÇü ÀÓÇöõÆ®¿¡ ´ëÇÑ °ü½É Áõ°¡, ½Å°æÇ÷°ü ¹× ±¸Á¶Àû ½ÉÀå ÁßÀç¿¡ ´ëÇÑ ÀÀ¿ë ºÐ¾ß È®´ë, Çõ½ÅÀûÀÎ ±â±â¿¡ ´ëÇÑ Áö¿øÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÃËÁøµÉ °ÍÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÃÖ¼Ò Ä§½À ±â±â ¼³°èÀÇ Çõ½Å, »ýü ÀûÇÕ¼º ÄÚÆÃÀÇ °³¼±, ½º¸¶Æ® ¼¾¼­ ±â¼ú°úÀÇ ÅëÇÕ, Çü»ó ±â¾ï ½ºÅÙÆ® ¹× ÀÓÇöõÆ®ÀÇ °³¹ß, ·Îº¿ º¸Á¶ ¼ö¼úÀÇ Ã¤Åà µîÀÌ ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü Áúȯ(CVD)ÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´ÏƼ³î ±â¹Ý ÀÇ·á ±â±â ½ÃÀåÀº ¾ÕÀ¸·Î ¸î ³â µ¿¾È ¼ºÀåÀ» À̾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀº °ü»óµ¿¸Æ Áúȯ, ½É±Ù°æ»ö, ½ÉºÎÀü, ºÎÁ¤¸Æ, ³úÁ¹Áß µî ½ÉÀå°ú Ç÷°ü ÁúȯÀ» Æ÷°ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº ÀϹÝÀûÀ¸·Î Ç÷°üÀÇ ÇùÂø ¶Ç´Â Æó¼â·Î ÀÎÇØ ½ÉÀå°ú ´Ù¸¥ Àå±â·ÎÀÇ Ç÷·ù¿Í »ê¼Ò °ø±ÞÀÌ Á¦Çѵ˴ϴÙ. ½ÉÇ÷°ü ÁúȯÀÇ Áõ°¡ Ãß¼¼´Â ƯÈ÷ ¼±Áø±¹¿¡¼­ Àα¸ °í·ÉÈ­¿¡ ±âÀÎÇϸç, ¿¬·ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó CVD À§ÇèÀÌ ³ô¾ÆÁý´Ï´Ù. ´ÏƼ³î ±â¹Ý ÀÇ·á ±â±â´Â ´ÏƼ³î(´ÏÄ̰ú ƼŸ´½ÀÇ ÇÕ±Ý)ÀÇ µ¶Æ¯ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ ½ÉÇ÷°ü ÁúȯÀÇ Ä¡·á ¹× °ü¸®¿¡ ¸Å¿ì È¿°úÀûÀÓÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ½ÉÀå Çùȸ(American Heart Association)´Â 2024³â 1¿ù ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö°¡ 93¸¸ 1,578¸í¿¡ ´ÞÇϰí, 2023³â 92¸¸ 8,741¸í¿¡¼­ Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. Á¤»ç¸Á·üÀº ¾à°£ »ó½ÂÇØ, 10¸¸¸í´ç 233.3¸íÀÌ µÇ¾î, Àü³âÀÇ 224.4¸íÀ¸·ÎºÎÅÍ 4.0% »ó½ÂÇß½À´Ï´Ù.±× °á°ú, ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÉÇ÷°ü Ä«Å×ÅÍ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

´ÏƼ³î ±â¹Ý ÀÇ·á±â±â ½ÃÀå ±â¾÷µéÀº ¼ö¼ú È¿À²¼ºÀ» Çâ»ó½Ã۰í ȯÀÚ È¸º¹À» °³¼±Çϱâ À§ÇØ ÀÚ±Þ È®ÀåÇü ´ÏƼ³î ½ºÅÙÆ®-Àü±Ø°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇÏ´Â µ¥ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ÀÚ±Þ È®ÀåÇü ´ÏƼ³î ½ºÅÙÆ®-Àü±ØÀº ü³»¿¡ »ðÀÔµÇ¸é ¹Ì¸® ¼³Á¤µÈ ÇüÅ·ΠÀÚµ¿ È®ÀåµÇ´Â ´ÏƼ³î ½ºÅÙÆ®·Î Á¦ÀÛµÈ ÇÏÀ̺긮µå ÀåÄ¡ÀÔ´Ï´Ù. ÀÌ ±â±â¿¡´Â ½Å°æ, Ç÷°ü, ³ú µî »ý¹°ÇÐÀû Á¶Á÷À¸·ÎºÎÅÍ Àü±â ÀÚ±ØÀ̳ª ±â·ÏÀ» À§ÇØ ¼³°èµÈ ³»ÀåÇü Àü±ØÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 9¿ù ¹Ì±¹ ±â¾÷ SynchronÀº ÀÚü È®ÀåÇü ´ÏƼ³î ½ºÅÙÆ®-Àü±Ø ¹è¿­À» »ç¿ëÇÏ´Â Stentrode BCI ÀÓÇöõÆ®¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ÀåÄ¡´Â °æÁ¤¸ÆÀ» ÅëÇØ ¿îµ¿ ÇÇÁú ±ÙóÀÇ »óºÎ »çÁöµ¿¸ÆÀ¸·Î Àü´ÞµÇ¸ç, ¾à 20ºÐ ³»¿¡ ÃÖ¼Ò Ä§½ÀÀû »ðÀÔÀÌ °¡´ÉÇÕ´Ï´Ù. ¾ãÀº µðÀÚÀÎ(1.3mm Àü±Ø)°ú ³·Àº ¹æ»ç·ÂÀ¸·Î Á¤¸Æ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϸç, Ç÷¡Æ¼³Ñ Àü±ØÀº ¿îµ¿ Àǵµ¸¦ µðÁöÅÐ Á¦¾î À§ÇØ ÇØµ¶ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, Äڷγª 19 ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°, ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Nitinol-based medical devices are healthcare instruments made from a nickel-titanium alloy known for its shape memory and superelastic characteristics. These devices are designed to adapt to body movements or temperature changes, making them suitable for minimally invasive procedures. Common uses include orthopedic implants, surgical tools, and dental devices.

The main product categories in nitinol-based medical devices include stents, guidewires, retrieval devices, catheters, and others. Stents are small, tube-shaped implants that help keep narrowed or blocked blood vessels open. These devices are used in various medical fields such as cardiovascular care, urology, dentistry, and more. They are primarily employed in hospitals, ambulatory surgical centers, specialty clinics, and other healthcare settings.

The nitinol based medical device market research report is one of a series of new reports from The Business Research Company that provides nitinol based medical device market statistics, including the nitinol based medical device industry global market size, regional shares, competitors with the nitinol based medical device market share, detailed nitinol based medical device market segments, market trends, and opportunities, and any further data you may need to thrive in the nitinol based medical device industry. This nitinol based medical device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nitinol-based medical device market size has grown rapidly in recent years. It will grow from $18.99 billion in 2024 to $21.06 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth during the historical period can be attributed to factors such as the rising demand for minimally invasive procedures, the increasing prevalence of cardiovascular and orthopedic conditions, the growing geriatric population, the enhanced biocompatibility and flexibility of Nitinol, the expansion of healthcare infrastructure, and favorable regulatory approvals for innovative devices.

The nitinol-based medical device market size is expected to see rapid growth in the next few years. It will grow to $31.6 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The projected growth in the forecast period is driven by factors including the rising demand for minimally invasive procedures, the increasing use of Nitinol in robotic-assisted surgeries, a growing focus on patient-specific and customizable implants, expanding applications in neurovascular and structural heart interventions, and supportive regulatory frameworks for innovative devices. Key trends during the forecast period include innovations in minimally invasive device design, enhanced biocompatibility coatings, integration with smart sensor technologies, the development of shape-memory stents and implants, and the adoption of robotic-assisted surgeries.

The rising prevalence of cardiovascular diseases (CVD) is expected to drive the growth of the nitinol-based medical device market in the coming years. Cardiovascular diseases encompass a variety of heart and blood vessel disorders, such as coronary artery disease, heart attacks, heart failure, arrhythmias, and stroke. These conditions typically involve the narrowing or blockage of blood vessels, which limits blood flow and oxygen to the heart and other organs. The increase in cardiovascular diseases can be attributed to aging populations, especially in developed countries, where the risk of CVD increases with age. Nitinol-based medical devices have proven to be highly effective in treating and managing cardiovascular diseases due to the unique properties of nitinol, an alloy of nickel and titanium. For example, the American Heart Association, a U.S.-based nonprofit organization, reported in January 2024 that the number of deaths caused by cardiovascular diseases reached 931,578, up from 928,741 in 2023. Additionally, the age-adjusted death rate from CVD increased slightly, reaching 233.3 per 100,000, a 4.0% rise from the previous year's rate of 224.4 per 100,000. As a result, the growing prevalence of cardiovascular diseases is driving the market for cardiovascular catheters.

Companies in the nitinol-based medical device market are focusing on developing innovative solutions, such as self-expanding nitinol stent-electrodes, to enhance surgical efficiency and improve patient recovery. A self-expanding nitinol stent-electrode is a hybrid device made from a nitinol stent that automatically expands into a predetermined shape once deployed in the body. It also features embedded electrodes designed for electrical stimulation or recording from biological tissues such as nerves, blood vessels, or the brain. For example, in September 2024, U.S.-based company Synchron introduced its Stentrode BCI implant, which uses a self-expanding nitinol stent-electrode array. This device is delivered via the jugular vein to the superior sagittal sinus near the motor cortex, allowing minimally invasive placement in approximately 20 minutes. The thin design (1.3mm lead) with low radial force minimizes venous damage, while the platinum electrodes decode motor intent for digital control.

In November 2022, Sweden-based alloy company Alleima AB acquired Endosmart Gesellschaft fur Medizintechnik GmbH (Endosmart) for an undisclosed amount. This acquisition strengthens Alleima's position in the medical sector by enhancing its product portfolio, expanding its market presence, and creating operational synergies through shared resources and cross-selling opportunities. Endosmart, based in Germany, specializes in designing and manufacturing medical devices and components using nitinol, a shape-memory alloy.

Major players in the nitinol based medical device market are Medtronic plc, Zimmer Biomet Holdings, Ametek Inc., Arthrex, Teleflex Incorporated, Nordson Medical, Cook Medical, Cordis, Seisa Medical, Fort Wayne Metals, Confluent Medical Technologies, Norman Noble Inc., Endologix, Resonetics, GEE Nitinol, Balton, EndoSmart GmbH, Ingpuls Medical, Vascotube, and Metalwerks PMD.

North America was the largest region in the nitinol-based medical device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nitinol-based medical device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nitinol-based medical device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nitinol-based medical device market consists of sales of products including nitinol, orthopedic fixation devices, endoscopic components, surgical sutures, dental archwires, embolic protection devices, and spinal implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nitinol Based Medical Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nitinol based medical device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for nitinol based medical device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nitinol based medical device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Nitinol Based Medical Device Market Characteristics

3. Nitinol Based Medical Device Market Trends And Strategies

4. Nitinol Based Medical Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Nitinol Based Medical Device Growth Analysis And Strategic Analysis Framework

6. Nitinol Based Medical Device Market Segmentation

7. Nitinol Based Medical Device Market Regional And Country Analysis

8. Asia-Pacific Nitinol Based Medical Device Market

9. China Nitinol Based Medical Device Market

10. India Nitinol Based Medical Device Market

11. Japan Nitinol Based Medical Device Market

12. Australia Nitinol Based Medical Device Market

13. Indonesia Nitinol Based Medical Device Market

14. South Korea Nitinol Based Medical Device Market

15. Western Europe Nitinol Based Medical Device Market

16. UK Nitinol Based Medical Device Market

17. Germany Nitinol Based Medical Device Market

18. France Nitinol Based Medical Device Market

19. Italy Nitinol Based Medical Device Market

20. Spain Nitinol Based Medical Device Market

21. Eastern Europe Nitinol Based Medical Device Market

22. Russia Nitinol Based Medical Device Market

23. North America Nitinol Based Medical Device Market

24. USA Nitinol Based Medical Device Market

25. Canada Nitinol Based Medical Device Market

26. South America Nitinol Based Medical Device Market

27. Brazil Nitinol Based Medical Device Market

28. Middle East Nitinol Based Medical Device Market

29. Africa Nitinol Based Medical Device Market

30. Nitinol Based Medical Device Market Competitive Landscape And Company Profiles

31. Nitinol Based Medical Device Market Other Major And Innovative Companies

32. Global Nitinol Based Medical Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nitinol Based Medical Device Market

34. Recent Developments In The Nitinol Based Medical Device Market

35. Nitinol Based Medical Device Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â